Pharmacological targeting of the cancer epigenome
Epigenetic dysregulation is increasingly appreciated as a hallmark of cancer, including
disease initiation, maintenance and therapy resistance. As a result, there have been …
disease initiation, maintenance and therapy resistance. As a result, there have been …
Aberrant glycosylation as immune therapeutic targets for solid tumors
Y Matsumoto, T Ju - Cancers, 2023 - mdpi.com
Simple Summary Glycosylation is one of the most pivotal post-translational modifications on
all types of biomolecules for the formation of glycoproteins, glycolipids, and glycoRNAs in a …
all types of biomolecules for the formation of glycoproteins, glycolipids, and glycoRNAs in a …
ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK. CAR-T cells
Selection of the best tumor antigen is critical for the therapeutic success of chimeric antigen
receptor (CAR) T cells in hematologic malignancies and solid tumors. The anaplastic …
receptor (CAR) T cells in hematologic malignancies and solid tumors. The anaplastic …
Current and emerging biomarkers: Impact on risk stratification for neuroblastoma
MS Irwin, KC Goldsmith - Journal of the National Comprehensive Cancer …, 2024 - jnccn.org
Neuroblastoma has heterogenous clinical presentations that are reflected by several well-
defined clinical factors and biomarkers. Combinations of these clinical and biologic …
defined clinical factors and biomarkers. Combinations of these clinical and biologic …
A developmental biliary lineage program cooperates with Wnt activation to promote cell proliferation in hepatoblastoma
Cancers evolve not only through the acquisition and clonal transmission of somatic
mutations but also by epigenetic mechanisms that modify cell phenotype. Here, we use …
mutations but also by epigenetic mechanisms that modify cell phenotype. Here, we use …
[HTML][HTML] Hopes on immunotherapy targeting B7-H3 in neuroblastoma
R Pulido, CE Nunes-Xavier - Translational Oncology, 2023 - Elsevier
Neuroblastoma is one of the most aggressive cancer forms in children, with highly
heterogenous clinical manifestations ranging from spontaneous regression to high …
heterogenous clinical manifestations ranging from spontaneous regression to high …
[HTML][HTML] Targeting EZH2 in neuroblastoma
Neuroblastoma is one of the commonest extra-cranial pediatric tumors, and accounts for
over 15% of all childhood cancer mortality. Risk stratification for children with neuroblastoma …
over 15% of all childhood cancer mortality. Risk stratification for children with neuroblastoma …
Biology of GD2 ganglioside: implications for cancer immunotherapy
P Machy, E Mortier, S Birklé - Frontiers in Pharmacology, 2023 - frontiersin.org
Part of the broader glycosphingolipid family, gangliosides are composed of a ceramide
bound to a sialic acid-containing glycan chain, and locate at the plasma membrane …
bound to a sialic acid-containing glycan chain, and locate at the plasma membrane …
Deciphering mouse brain spatial diversity via glyco-lipidomic mapping
Gangliosides in the brain play a crucial role in modulating the integrity of vertebrate central
nervous system in a region-specific manner. However, to date, a comprehensive structural …
nervous system in a region-specific manner. However, to date, a comprehensive structural …
Bioactive sphingolipids as emerging targets for signal transduction in cancer development
W Jia, J Yuan, J Zhang, S Li, W Lin, B Cheng - Biochimica et Biophysica …, 2024 - Elsevier
Sphingolipids, crucial components of cellular membranes, play a vital role in maintaining
cellular structure and signaling integrity. Disruptions in sphingolipid metabolism are …
cellular structure and signaling integrity. Disruptions in sphingolipid metabolism are …